Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Harris, John E.UMass Chan Affiliations
Department of Medicine, Division of DermatologyDocument Type
Journal ArticlePublication Date
2017-04-01Keywords
AutoimmunityCellular stress
Chemical
Leukoderma
Monobenzone
Phenol
Rhododendrol
Vitiligo
Cellular and Molecular Physiology
Dermatology
Skin and Connective Tissue Diseases
Metadata
Show full item recordAbstract
Chemical-induced depigmentation of the skin has been recognized for more than 75 years, first as an occupational hazard but then extending to those using household commercial products as common as hair dyes. Since their discovery, these chemicals have been used therapeutically in patients with severe vitiligo to depigment their remaining skin and improve their appearance. Because chemical-induced depigmentation is clinically and histologically indistinguishable from nonchemically induced vitiligo, and because these chemicals appear to induce melanocyte autoimmunity, this phenomenon should be known as "chemical-induced vitiligo," rather than less accurate terms that have been previously used.Source
Dermatol Clin. 2017 Apr;35(2):151-161. doi: 10.1016/j.det.2016.11.006. Link to article on publisher's siteDOI
10.1016/j.det.2016.11.006Permanent Link to this Item
http://hdl.handle.net/20.500.14038/36709PubMed ID
28317525Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1016/j.det.2016.11.006